Clinical Trial Update: High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating high-cutoff hemodialysis in patients with advanced cardiac AL amyloidosis and end-stage renal disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Light-chain Amyloidosis

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Primary Amyloidosis of Light Chain Type | Phase 2 | Status: WITHDRAWN